Disturbance of endothelial function in heart disease patients. Classification, diagnostic and treatment options;Az endothelfunkció zavara szívbetegekben. Klasszifikáció, diagnosztikus és terápiás lehetöségek

Orvoskepzes

Volumn 76, Issue 3, 2001, Pages 210-220

  Jusztina, B ^a   Istvan H ^a   Robert Gabor K ^a   Istvan P ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; C REACTIVE PROTEIN; ENDOTHELIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR; UROKINASE; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOCARDIOGRAPHY; ANTICOAGULATION; ATHEROSCLEROSIS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ENDOTHELIUM LESION; HEART DISEASE; HUMAN; INFLAMMATION; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; STEADY STATE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

EID: 0034783310     PISSN: 00306037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. The obligatory role of endothelial cells in the relaxation of the arterial smooth muscle by acethylcholine
2. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide
3. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischaemia and reperfusion in the rat hearts
4. Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxidesynthesis. Evidence for an endothelin-mediated mechanism
5. Local L arginine delivery after balloon angioplasty reduces monocyta binding and induces apoptosis
6. Endothelial dysfunction and collagen accumulation: Two independent factors for restenosis and constrictive remodeling after experimental angioplasty
7. Vascular effects of estrogen and vitamin E therapies in postmenopausal women
8. The direct antiatherogenic effect of estrogen is present, absent, or reversed depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits
9. Novel mechanism for endothelial dysfunction: Dysregulation of dimethylarginine demethylaminohydrolase
10. Endogenous nitricoxide synthase inhibitor: A novel marker of atherosclerosis
11. Endothelial dysfunction and coronary heart disease. Interaction of endothelium and thrombocytes
12. Nitrate resistance in platelets from patients with stable pectoris
13. High dose heparin impairs nitric oxide pathway and vasomotion in rats
14. Non antocoagulant heparin prevents coronary endothelial dysfunction after brief ischaemia-reperfusion injury in the dog
15. Endothelial dysfunction in chronicmyocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase-expression. Role of enhanced vascular superoxide production
16. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
17. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells
18. Cellular signaling by peptides of the endothelin gene family
19. Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1: Cross-talk between G protein-coupled receptors and pp60c-src
20. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria
21. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide
22. Endothelin has potent direct inotropic and chronotropic effects in cultured heart cells
23. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction
24. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats
25. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy
26. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
27. Evidence for endothelin-1 mediated vasoconstriction in severe chronic heart failure. Endothelin antagonism in heart failure
28. Endothelin in human congestive heart failure
29. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
30. Prognostic value of plasma endothelin-1 in patients with chronic heart failure
31. Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury
32. Endothelin-1 promotes neointima formation after balloon angioplasty in the rat
33. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670
34. Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries
35. Selective antagonism of the ET(A) receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs
36. Application of serial in vivo magnetic resonance imaging to evaluate the efficacy of endothelin receptor antagonist SB 217242 in the rat carotid artery model of neointima formation
37. Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model
38. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension
39. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
40. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome
41. Stimulation of endothelin-1 gene expression by insulin in endothelial cells
42. Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells
43. Plasma endothelin-1 levels in patients with angina pectoris and normal coronary angiograms
44. Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms
45. Altered endothelin-1 binding following balloon angioplasty of pig coronaryarteries: Effect of the ETA receptor antagonist, LU 135252
46. Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia best-PJM
47. Vascular endothelin-1 gene expression and synthesis and effect on renal type 1 collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in rats
48. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: Contribution of nitricoxide and Ca(2+) -activated K(+) channels
49. Proinflammatory mediators chronically downregulate the formation of the endothelium derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism
50. Increase in the adhesion molecule P-selectin in the endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1
51. PPAR alpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells
52. Androgen exposure increases human monocyta adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule 1
53. Increased plasma levels of soluble vascular cellular adhesion molecule-1 in patients with chest pain and angiographically normal coronary arteries
54. Serum levels of circulating adhesion molecules after coronary angioplasty
55. Circulating cell adhesion molecules ang endothelial markers before and after transluminal angioplasty in periferial arterialocclusive disease
56. Acute myocardial infarction and increased solubleintercellular adhesion molecule-1: A marker of vascular inflammation and a risk of early restenosis?
57. Protective effects of preconditioning in cultured rat endothelial cells: Effects on neutrophil adhesion and expression of ICAM-1 after anoxia and reoxygenation
58. Simvastatin preserves the ischaemiareperfused myocardium in normocholesterolemic rat hearts
59. Von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis
60. The variable role of inflammation in acute coronary syndromes and in restenosis
61. Acute myocardial infarction and increased soluble intercellular adhesion molecule-1: A marker of vascular inflammation and a risk of early restenosis?
62. Nitric oxide decreases cytokine induced endothelium activation. Nitric oxide selectivelly reduces endothelial expression of adhesion molecules and pro-inflammatory cytokines
63. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappa b and induces tissue factor and PA1 expression: A potential link to accelerated arteriosclerosis
64. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction
65. Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis
66. Urokinase receptor (uPAR, CD 87) is a platelet receptor important for kinetics and TNF-induced endothelial adhesion in mice
67. Effects of inhibition of nitric oxide formation on regional blood flowin experimental myocardial infarction
68. Endocardial funtion in chronic congestive heart failure
69. Selective attenuation of endothelium mediated vasodilation in ahterosclerotic human coronary arteries
70. Coronary vasomotor response to acethylcholine relates to risk factors for coronary artery disease
71. Long term follow-up of patients with mild coronary artery disease and endothelial dysfunction
72. Angiographic demonstration of hyeperconstriction induced by serotonin and aggregating platelets in porcine coronary arteries with regenarated endothelium
73. The endothelium: A pivotal role in health and cardiovascular disease
74. Preserved Endothelium-dependent vasodilation in coronary segments previously treated with balloon angioplasty and intracoronary irradiation
75. Is it all in the genes? Nitric oxide synthase and coronary vasospasm
76. Nitric oxide activity is deficient in spasm arteries of patients with coronary spstic angina
77. (-786) C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm
78. Suppression of hyperventilation induced attacks with infusion of B-type (brain) natriuretic peptide in patients with variant angina
79. Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model
80. Endothelial vasodilatorfunction is preserved at the spastic/inflammatory coronary lasionsin pigs
81. Alpha adrenergic coronary vasocontstriction and myocardial ischaemia in human
82. Coronary vasospasm induced during isoproterenol head-up tilt test
83. Hyperventilation as a specific test for diagnosis of coronary artery spasm
84. Calcium-Channel Blockers and Cardiac arrest AHA
85. Effects of autonomic neuropathyon coronary blood flow in patients with diabetes mellitus
86. Regional myocardia sympathetic dysinnervation in patients with coronary vasospasm
87. Coronary artery slow flow associated with angina pectoris and hypotension
88. Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteries
89. Long-term clinical course of patients with angina and angiographically normal coronary arteries
90. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart
91. Inapproppriate microvascular constriction produced transient ST segment elevation in patients with syndrome X
92. Angina pectoris caused by coronary microvascular spasm
93. Endothelium dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndroma X
94. Angiotensin-converting enzyme inhibition with quinalapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND (Trial on Reversing Endothelial Dysfunction) study
95. ACE inhibition and endothelial function: The BANFF study
96. Quinalapril on Vascular ACE and determinants of ischaemia: The Quo Vadis study
97. Prognostic impact of coronary vasodilator dysfunction adverse long-term outcome of coronary heart disease